News Channels

17 Mar 2020 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
17 Mar 2020 Imfinzi confirmed a sustained overall survival benefit in final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
17 Mar 2020 Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in haemophilia A and B with or without inhibitors
16 Mar 2020 GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
16 Mar 2020 Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
16 Mar 2020 Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19
16 Mar 2020 Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals Enter into Definitive Merger Agreement
16 Mar 2020 Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis
16 Mar 2020 BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
16 Mar 2020 BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
15 Mar 2020 Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline
15 Mar 2020 Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
13 Mar 2020 EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
13 Mar 2020 Pluristem and Charité University of Medicine Berlin Join Forces Targeting Potential Treatment for Respiratory and Inflammatory Intratissue Complications Caused by COVID-19
13 Mar 2020 Medicago Announces Production of a Viable Vaccine Candidate for COVID-19
13 Mar 2020 FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections
13 Mar 2020 Artugen Therapeutics Announces First Patient Dosed with ART24, Artugen’s First Clinical Product Candidate for Prevention of Recurrence of Clostridium Difficile Infection
13 Mar 2020 Henlius Received Acceptance Notification for Clinical Trial Application from NMPA for its Denosumab Biosimilar HLX14
13 Mar 2020 AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
13 Mar 2020 UCB provides an update on Phase 2b padsevonil safety and efficacy study in epilepsy (ARISE)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up